| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Amantadine disrupts lysosomal gene expression: A hypothesis for COVID19 treatment
|
Smieszek, Sandra P.
|
|
|
55 |
6 |
p.
|
artikel
|
| 2 |
Can post-exposure prophylaxis for COVID-19 be considered as an outbreak response strategy in long-term care hospitals?
|
Lee, Sun Hee
|
|
|
55 |
6 |
p.
|
artikel
|
| 3 |
Chloroquine as a prophylactic agent against COVID-19?
|
Gendrot, Mathieu
|
|
|
55 |
6 |
p.
|
artikel
|
| 4 |
Combination of polymyxin B and minocycline against multidrug-resistant Klebsiella pneumoniae: interaction quantified by pharmacokinetic/pharmacodynamic modelling from in vitro data
|
Zhao, Chenyan
|
|
|
55 |
6 |
p.
|
artikel
|
| 5 |
Contemporaneous management of ampicillin infusions in the outpatient setting through the use of therapeutic drug monitoring
|
Parsonson, Fiona
|
|
|
55 |
6 |
p.
|
artikel
|
| 6 |
Coronavirus disease 2019 (COVID-19): first indication of efficacy of Gene-Eden-VIR/Novirin in SARS-CoV-2 infection
|
Polansky, Hanan
|
|
|
55 |
6 |
p.
|
artikel
|
| 7 |
Corrigendum to ``Emergence of high level and stable metronidazole resistance in Clostridioides difficile'' [International Journal of Antimicrobial Agents Vol. 55 (2020) 5830]
|
Arcay, Ricardo M.
|
|
|
55 |
6 |
p.
|
artikel
|
| 8 |
Crushed application of sofosbuvir and velpatasvir in a patient with swallowing disorder
|
van Seyen, Minou
|
|
|
55 |
6 |
p.
|
artikel
|
| 9 |
Cytokine storm and immunomodulatory therapy in COVID-19: Role of chloroquine and anti-IL-6 monoclonal antibodies
|
Zhao, Ming
|
|
|
55 |
6 |
p.
|
artikel
|
| 10 |
Determinants of vancomycin nephrotoxicity when administered to outpatients as a continuous 24-hour infusion
|
Chambers, Stephen T.
|
|
|
55 |
6 |
p.
|
artikel
|
| 11 |
Dissemination of carbapenem-resistant Pseudomonas aeruginosa isolates and their susceptibilities to ceftolozane-tazobactam in Germany
|
Kresken, Michael
|
|
|
55 |
6 |
p.
|
artikel
|
| 12 |
Drug repositioning is an alternative for the treatment of coronavirus COVID-19
|
Serafin, Marissa B.
|
|
|
55 |
6 |
p.
|
artikel
|
| 13 |
Emergence of a novel conjugative hybrid virulence multidrug-resistant plasmid in extensively drug-resistant Klebsiella pneumoniae ST15
|
Li, Ruichao
|
|
|
55 |
6 |
p.
|
artikel
|
| 14 |
Evolutionary landscapes of Pseudomonas aeruginosa towards ribosome-targeting antibiotic resistance depend on selection strength
|
Sanz-García, Fernando
|
|
|
55 |
6 |
p.
|
artikel
|
| 15 |
Excessive lysosomal ion-trapping of hydroxychloroquine and azithromycin
|
Derendorf, Hartmut
|
|
|
55 |
6 |
p.
|
artikel
|
| 16 |
Global coronavirus disease 2019: What has daily cumulative index taught us?
|
Lai, Chih-Cheng
|
|
|
55 |
6 |
p.
|
artikel
|
| 17 |
Greater optimisation of pharmacokinetic/pharmacodynamic parameters through a loading dose of intravenous colistin in paediatric patients
|
Wacharachaisurapol, Noppadol
|
|
|
55 |
6 |
p.
|
artikel
|
| 18 |
Hot topics in diabetic foot infection
|
Saeed, Kordo
|
|
|
55 |
6 |
p.
|
artikel
|
| 19 |
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page
|
|
|
|
55 |
6 |
p.
|
artikel
|
| 20 |
Interregional spread in Spain of linezolid-resistant Enterococcus spp. isolates carrying the optrA and poxtA genes
|
Moure, Zaira
|
|
|
55 |
6 |
p.
|
artikel
|
| 21 |
May drug-related cardiovascular toxicities persist after hospital discharge in COVID-19 patients?
|
Kara, Emre
|
|
|
55 |
6 |
p.
|
artikel
|
| 22 |
Molecular characterisation of clinical pandrug-resistant Alcaligenes faecalis strain MUB14
|
Majewski, Piotr
|
|
|
55 |
6 |
p.
|
artikel
|
| 23 |
Multicentre study of risk factors for mortality in patients with Acinetobacter bacteraemia receiving colistin treatment
|
Lee, Yi-Tzu
|
|
|
55 |
6 |
p.
|
artikel
|
| 24 |
New insights into the mechanisms of colistin resistance in Klebsiella aerogenes of clinical origin
|
Liao, Weichao
|
|
|
55 |
6 |
p.
|
artikel
|
| 25 |
Opportunities for antimicrobial stewardship among carbapenem-treated patients in 18 North American hospitals
|
Wagner, Jamie L.
|
|
|
55 |
6 |
p.
|
artikel
|
| 26 |
Perspectives: potential therapeutic options for SARS-CoV-2 patients based on feline infectious peritonitis strategies: central nervous system invasion and drug coverage
|
Olsen, Mark
|
|
|
55 |
6 |
p.
|
artikel
|
| 27 |
Pharmacokinetic/pharmacodynamic adequacy of polymyxin B against extensively drug-resistant Gram-negative bacteria in critically ill, general ward and cystic fibrosis patient populations
|
Xie, Jiao
|
|
|
55 |
6 |
p.
|
artikel
|
| 28 |
Pharmacological perspective: glycyrrhizin may be an efficacious therapeutic agent for COVID-19
|
Luo, Pan
|
|
|
55 |
6 |
p.
|
artikel
|
| 29 |
Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence
|
Wang, Lisheng
|
|
|
55 |
6 |
p.
|
artikel
|
| 30 |
SARS-CoV-2 was already spreading in France in late December 2019
|
Deslandes, A.
|
|
|
55 |
6 |
p.
|
artikel
|
| 31 |
Spread of multidrug-resistant IncHI1 plasmids carrying ESBL gene bla CTX-M-1 and metabolism operon of prebiotic oligosaccharides in commensal Escherichia coli from healthy horses, France
|
de Lagarde, Maud
|
|
|
55 |
6 |
p.
|
artikel
|
| 32 |
Tetrahydroporphyrin-tetratosylate (THPTS)-based photodynamic inactivation of critical multidrug-resistant bacteria in vitro
|
Ziganshyna, Svitlana
|
|
|
55 |
6 |
p.
|
artikel
|
| 33 |
Title Page & Editorial Board
|
|
|
|
55 |
6 |
p.
|
artikel
|
Tijdschrift beschrijving